Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer (SOFT)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2013 by International Breast Cancer Study Group.
Recruitment status was  Active, not recruiting
National Cancer Institute (NCI)
Breast International Group
Cancer and Leukemia Group B
NCIC Clinical Trials Group
North Central Cancer Treatment Group
NSABP Foundation Inc
Southwest Oncology Group
Information provided by (Responsible Party):
International Breast Cancer Study Group Identifier:
First received: August 6, 2003
Last updated: November 6, 2013
Last verified: November 2013
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):